Vault-13

Empery Asset Management, LP

NEW YORK, NY · CIK 1469336 · 13F filing filed 2026-08-11

SEC-registered investment adviser since 2021 · limited partnership

$86.5m reported value +4.2% vs Q1 2026
32positions
90.7%in top 10
12 new 0 added 7 reduced 12 sold out vs Q1 2026

Holdings, Q2 2026

The small lines show how much was held over the last 4 quarters (adjusted for stock splits).

#SecurityTickerShares Value% of portfolioChangeShares change
1 X4 PHARMACEUTICALS INC COM NEW XFOR XFOR 6,930,591 $32.4m37.43% 37.43% ReducedShares held: Q3 2025 —, Q4 2025 9.0m, Q1 2026 8.9m, Q2 2026 6.9m -2.0m -2,013,527 -22.5%
2 EMPERY DIGITAL INC COM NEW EMPD EMPD 2,930,345 $10.4m12.06% 12.06% UnchangedShares held: Q3 2025 —, Q4 2025 2.9m, Q1 2026 2.9m, Q2 2026 2.9m
3 NERVGEN PHARMA CORP COM NGEN NGEN 4,000,000 $8.2m9.53% 9.53% NewShares held: Q3 2025 —, Q4 2025 0, Q1 2026 0, Q2 2026 4.0m
4 PRECISION BIOSCIENCES INC COM NEW DTIL DTIL 776,093 $6.1m7.05% 7.05% ReducedShares held: Q3 2025 —, Q4 2025 2.2m, Q1 2026 2.0m, Q2 2026 776.1k -1.2m -1,192,786 -60.6%
5 CLENE INC COM NEW CLNN CLNN 916,532 $5.6m6.52% 6.52% NewShares held: Q3 2025 —, Q4 2025 0, Q1 2026 0, Q2 2026 916.5k
6 ANNOVIS BIO INC COM ANVS ANVS 2,401,476 $4.5m5.17% 5.17% NewShares held: Q3 2025 —, Q4 2025 0, Q1 2026 0, Q2 2026 2.4m
7 LANTERN PHARMA INC COM LTRN LTRN 842,669 $3.5m4.06% 4.06% NewShares held: Q3 2025 —, Q4 2025 0, Q1 2026 0, Q2 2026 842.7k
8 AMC ENTMT HLDGS INC CL A NEW AMC AMC 1,714,043 $3.3m3.77% 3.77% NewShares held: Q3 2025 —, Q4 2025 0, Q1 2026 0, Q2 2026 1.7m
9 TENAYA THERAPEUTICS INC COM TNYA TNYA 3,863,115 $2.9m3.30% 3.30% ReducedShares held: Q3 2025 —, Q4 2025 5.4m, Q1 2026 4.3m, Q2 2026 3.9m -423.8k -423,818 -9.9%
10 ONE AND ONE GREEN TECHNOLOGI USD CL A ORD SHS YDDL YDDL 761,706 $1.5m1.78% 1.78% NewShares held: Q3 2025 —, Q4 2025 0, Q1 2026 0, Q2 2026 761.7k
11 CYNGN INC COM CYN CYN 927,059 $1.3m1.49% 1.49% ReducedShares held: Q3 2025 —, Q4 2025 0, Q1 2026 957.8k, Q2 2026 927.1k -30.7k -30,725 -3.2%
12 VENU HLDG CORP COM VENU VENU 512,818 $1.2m1.35% 1.35% ReducedShares held: Q3 2025 —, Q4 2025 0, Q1 2026 1.0m, Q2 2026 512.8k -494.9k -494,911 -49.1%
13 GREENLAND ENERGY CO *W EXP 04/21/203 GLNDW GLNDW 1,000,000 $850.0k0.98% 0.98% NewShares held: Q3 2025 —, Q4 2025 0, Q1 2026 0, Q2 2026 1.0m
14 UR-ENERGY INC COM URG URG 620,136 $843.4k0.98% 0.98% UnchangedShares held: Q3 2025 —, Q4 2025 0, Q1 2026 620.1k, Q2 2026 620.1k
15 SATELLOS BIOSCIENCE INC COM MSLE MSLE 107,100 $832.7k0.96% 0.96% ReducedShares held: Q3 2025 —, Q4 2025 0, Q1 2026 230.1k, Q2 2026 107.1k -123.0k -123,000 -53.5%
16 JAGUAR URANIUM CORP CL A COM SHS JAGU JAGU 487,500 $814.1k0.94% 0.94% UnchangedShares held: Q3 2025 —, Q4 2025 0, Q1 2026 487.5k, Q2 2026 487.5k
17 CELLECTAR BIOSCIENCES INC COM NEW CLRB CLRB 189,605 $527.1k0.61% 0.61% NewShares held: Q3 2025 —, Q4 2025 0, Q1 2026 0, Q2 2026 189.6k
18 SCYNEXIS INC COM SCYX SCYX 126,451 $514.7k0.60% 0.60% NewShares held: Q3 2025 —, Q4 2025 0, Q1 2026 0, Q2 2026 126.5k
19 REIN THERAPEUTICS INC COM NEW RNTX RNTX 370,834 $385.7k0.45% 0.45% NewShares held: Q3 2025 —, Q4 2025 0, Q1 2026 0, Q2 2026 370.8k
20 BTC DIGITAL LTD SHS NEW BTCT BTCT 350,877 $288.9k0.33% 0.33% NewShares held: Q3 2025 —, Q4 2025 0, Q1 2026 0, Q2 2026 350.9k
21 BRIACELL THERAPEUTICS CORP *W EXP 01/15/203 BCTXL BCTXL 300,000 $267.0k0.31% 0.31% UnchangedShares held: Q3 2025 —, Q4 2025 0, Q1 2026 300.0k, Q2 2026 300.0k
22 MARIS TECH LTD *W EXP 02/04/202 MTEKW MTEKW 297,600 $58.0k0.07% 0.07% UnchangedShares held: Q3 2025 —, Q4 2025 297.6k, Q1 2026 297.6k, Q2 2026 297.6k
23 PARAZERO TECHNOLOGIES LTD SHS PRZO PRZO 113,771 $55.3k0.06% 0.06% ReducedShares held: Q3 2025 —, Q4 2025 0, Q1 2026 282.2k, Q2 2026 113.8k -168.4k -168,428 -59.7%
24 DUKE ROBOTICS CORP *W EXP 05/06/203 DUKRW DUKRW 35,000 $45.1k0.05% 0.05% NewShares held: Q3 2025 —, Q4 2025 0, Q1 2026 0, Q2 2026 35.0k
25 NUTRIBAND INC *W EXP 99/99/999 *W EXP 99/99/999 40,218 $40.2k0.05% 0.05% UnchangedShares held: Q3 2025 —, Q4 2025 40.2k, Q1 2026 40.2k, Q2 2026 40.2k
26 RENATUS TACTICAL ACQUIS *W EXP 05/15/203 RTACW RTACW 50,000 $38.0k0.04% 0.04% UnchangedShares held: Q3 2025 —, Q4 2025 50.0k, Q1 2026 50.0k, Q2 2026 50.0k
27 SPECTRAL AI INC *W EXP 99/99/999 MDAIW MDAIW 33,336 $18.5k0.02% 0.02% UnchangedShares held: Q3 2025 —, Q4 2025 33.3k, Q1 2026 33.3k, Q2 2026 33.3k
28 JEFFS BRANDS LTD *W EXP 08/26/202 NEXRW NEXRW 360,577 $10.4k0.01% 0.01% UnchangedShares held: Q3 2025 —, Q4 2025 360.6k, Q1 2026 360.6k, Q2 2026 360.6k
29 CEA INDUSTRIES INC *W EXP 02/11/202 BNCWW BNCWW 500,000 $9.2k0.01% 0.01% UnchangedShares held: Q3 2025 —, Q4 2025 500.0k, Q1 2026 500.0k, Q2 2026 500.0k
30 FGI INDUSTRIES LTD *W EXP 01/21/202 FGIWW FGIWW 83,928 $8.0k0.01% 0.01% UnchangedShares held: Q3 2025 —, Q4 2025 83.9k, Q1 2026 83.9k, Q2 2026 83.9k
31 NEUROSENSE THERAPEUTICS LTD *W EXP 11/10/202 NRSNW NRSNW 100,402 $6.3k0.01% 0.01% UnchangedShares held: Q3 2025 —, Q4 2025 100.4k, Q1 2026 100.4k, Q2 2026 100.4k
32 NEXGEL INC *W EXP 12/01/202 NXGLW NXGLW 90,000 $3.5k0.00% 0.00% UnchangedShares held: Q3 2025 —, Q4 2025 90.0k, Q1 2026 90.0k, Q2 2026 90.0k

Sold out since Q1 2026

SecurityTickerShares held beforeValue then
IMPERIAL PETE INC IMPP IMPP 877,645 $3.8m877.6k shares
U S ENERGY CORP DEL BSIN BSIN 1,917,844 $1.7m1.9m shares
SCYNEXIS INC 1,847,826 $1.7m1.8m shares
CRITICAL METALS CORP CRML CRML 132,039 $1.0m132.0k shares
PROMIS NEUROSCIENCES INC PMN PMN 60,353 $766.5k60.4k shares
SUPER LEAGUE ENTERPRISE INC SLE SLE 132,917 $491.8k132.9k shares
TALPHERA INC TLPH TLPH 590,481 $441.0k590.5k shares
BENITEC BIOPHARMA INC BNTC BNTC 30,440 $324.2k30.4k shares
ABITS GROUP INC ABTS ABTS 172,761 $266.1k172.8k shares
NASUS PHARMA LTD NSRX NSRX 45,803 $101.7k45.8k shares
BRIACELL THERAPEUTICS CORP BCTXZ BCTXZ 666,600 $93.3k666.6k shares
MEDICUS PHARMA LTD MDCXW MDCXW 12,100 $11.5k12.1k shares

Stakes above 5%

Companies where this manager has reported owning more than 5% of a class of shares, on Schedule 13D (may seek influence) or 13G (passive): its latest filing for each, from 19 Dec 2024 on.

CompanyTickerStakeChange ScheduleLast filed
EMPERY DIGITAL INC EMPD · 13D · filed 2026-09-03 EMPD 17.5%≈ $17.6m +1.8 pts 13D 2026-09-03
CELLECTAR BIOSCIENCES INC CLRB · 13G · filed 2026-08-04 CLRB 10.0%≈ $2.4m new 13G 2026-08-04
CYNGN INC CYN · 13G · filed 2026-04-22 CYN 10.0%≈ $2.0m +10.0 pts 13G 2026-04-22
SUPER LEAGUE ENTERPRISE INC 13G · filed 2026-01-22 10.0% new 13G 2026-01-22
X4 PHARMACEUTICALS INC XFOR · 13G · filed 2026-01-15 XFOR 10.0%≈ $42.2m no change 13G 2026-01-15
VOLCON INC 13G · filed 2025-05-07 10.0% new 13G 2025-05-07
SOBR SAFE INC 13G · filed 2025-01-16 10.0% new 13G 2025-01-16
GREENLANE HLDGS INC 13G · filed 2025-01-15 10.0% 13G 2025-01-15
OUTLOOK THERAPEUTICS INC OTLK · 13G · filed 2026-10-13 OTLK 8.7%≈ $33.8m +3.7 pts 13G 2026-10-13
DYADIC INTL INC DEL DYAI · 13G · filed 2026-10-15 DYAI 8.3%≈ $3.0m new 13G 2026-10-15
JIUZI HOLDINGS INC JZXN · 13G · filed 2025-10-21 JZXN 7.5% new 13G 2025-10-21
FEMASYS INC FEMY · 13G · filed 2026-10-15 FEMY 5.6%≈ $2.0m new 13G 2026-10-15

Trades reported as a company insider since 1 Apr 2026

Owning 10% or more of a company, or having someone on its board, makes this manager an insider there: it reports its trades in that company's shares on Form 4 within two business days. Open-market and private purchases and sales only.

DateCompanyTickerTradeShares ValueTheir holding
2026-09-01 EMPERY DIGITAL INC Co-Chief Executive Officer · See footnote EMPD Bought 500,000 $1.8m500.0k shares +11%
2026-08-13 EMPERY DIGITAL INC Co-Chief Executive Officer · See footnote EMPD Bought 750,000 $2.2m750.0k shares +20%
2026-08-12 EMPERY DIGITAL INC Co-Chief Executive Officer · See footnote EMPD Bought 650,000 $1.8m650.0k shares +21%